Olema Pharmaceuticals, Inc. (OLMA) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$162.45M | -25.5% |
| 2024 | -$129.47M | -34.0% |
| 2023 | -$96.66M | +7.8% |
| 2022 | -$104.79M | -47.4% |
| 2021 | -$71.10M | -221.4% |
| 2020 | -$22.12M | -412.5% |
| 2019 | -$4.32M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$162.45M | -25.5% |
| 2024 | -$129.47M | -34.0% |
| 2023 | -$96.66M | +7.8% |
| 2022 | -$104.79M | -47.4% |
| 2021 | -$71.10M | -221.4% |
| 2020 | -$22.12M | -412.5% |
| 2019 | -$4.32M | — |